By proceeding, you agree to our Terms of Use and Privacy Policy.
ygnus Technologies, part of Maravai LifeSciences, is the biopharmaceutical industry’s partner in host cell protein (HCP) and other process-related impurity detection and analytics.
22-24 March 2022
Europe’s fastest growing bioprocessing meeting is returning to Barcelona on 22-24 March, 2022, with more content, ground breaking science and practical case studies than ever before.
Event Ended
Hybrid
Paid
15-18 August 2022
The Bioprocessing Summit 2022 For more than 10 years, The Bioprocessing Summit has been recognized as the premier forum for industry leaders to share the latest research in bioprocess R&D, scale-up, quality and analytics.
Boston
05-08 December 2022
The European Cell and Gene Therapy Congress for ground-breaking manufacturing, commercialization and supply chain strategies. World renowned leaders share the latest analytical techniques & vector technologies to revolutionise your cell, gene & gene
Amsterdam
14-15 August 2023
Advances in host cell engineering, better expression of cell lines and optimization of cell culture processes, have greatly accelerated upstream processing in the last decade, resulting in today's antibody production yield of 10g/L or more. Meanwhile
Vaccines and mRNA-based vaccines have recently gained a lot of attention due to COVID-19. Cambridge Healthtech Institute’s 3rd Annual Vaccine Development and Manufacturing conference tackles the practical challenges facing the development, manufactur
Cambridge Healthtech Institute’s Gene Therapy CMC and Analytics conference uncovers the practical challenges facing the analysis, characterization, and quality of viral vector-based gene therapies for clinical and commercial supply, with dedicated se
The popular 11th Annual Rapid Methods to Assess Stability and Impurities in Biologics conference will bring together experts in formulation, analytical sciences, and process to discuss rapid and practical ways to accelerate prediction and screening f
Cambridge Healthtech Institute’s Cell Therapy CMC and Analytics conference focuses on the characterization, control, and quality of cell-based therapies, supported by in-depth case studies and insight from leading industry and academic representative
The biopharma industry is driven by the need to increase productivity, reduce cost, while maintaining product quality and consistency. Continuous biomanufacturing and process intensification are borne out of such need. CHI’s Intensified & Continuous
Characterizing and controlling process-related impurities, such as host cell proteins (HCPs), is a critical part of bioprocessing, with regulators now pressing companies for more data and questions emerging on the role of HCPs in emerging modalities.
14-17 August 2023
The Bioprocessing Summit 2023, now in its fifteenth year, stands as the premier global forum for industry leaders to converge and exchange groundbreaking advancements in bioprocess research and development, scale-up, quality, and analytics. This high
16-17 August 2023
The approval of COVID-19 vaccines was the breakthrough for mRNA-based technology, and it opened so many opportunities for mRNA-based vaccines and therapeutics. CHI’s 2nd Annual mRNA-Based Therapies conference will explore the technical challenges fac
Pharmaceutical companies today are increasingly harnessing the power of digitalization to drive scientific and operational excellence across the value chain, from R&D to manufacturing. Digitalization is a key enabler to smarter bioprocessing and to h
Industry analytical groups are facing increased pressure to deliver key studies faster than ever before – and at lower costs. Cambridge Healthtech Institute’s 10th Annual Accelerating Analytical Development conference offers a best practices forum in
Newer and more complex molecules coming down the pipeline are bringing a new set of challenges to the downstream process development team, leading to the search for innovative technologies to meet the demand for higher yield while maintaining product
The development of high-concentration protein formulations for traditional and novel biologic products can be challenging during manufacturing, storage, and delivery due to problems such as aggregation, precipitation, gelation, and high viscosity. Th
Cambridge Healthtech Institute’s Gene Therapy Manufacturing conference discusses the practical challenges facing the production, purification, and manufacturing of viral and non-vector-based gene therapies. Topics include: AAV and lentivirus upstream
CHI’s Cell Therapy Manufacturing conference examines the practical challenges in manufacturing autologous and allogenic cell therapies at scale, with dedicated sessions on cell processing, scalability, next-generation production technologies, automat